The Trump Administration’s White House Office of Drug Control Policy released its first National Drug Control Strategy on Thursday, January 31, 2019. The document outlines President Trump’s priorities regarding drug trafficking and drug use and provides strategic direction to federal...
Read moreIt has been an exciting year in the world of cannabis reform. From studies that underscore the therapeutic potential of cannabis to political changes that bode well for patients and consumers, there is much to celebrate. Before we close the...
Read moreIf you have seen the news lately, you know that the possibility of a partial government shutdown is looming. Although Congress has passed funding extensions, the President is threatening to veto any appropriations packages that do not contain sufficient funding...
Read moreDespite the anticipation of a major announcement at the 61st Commission on Narcotic Drugs relating to the international scheduling of cannabis, no announcement came from the World Health Organization (WHO) today. Many expected the WHO to issue a recommendation on...
Read moreThis week has been big for cannabis in electoral politics. Thanks to Tuesday’s election, thirty-three states now have a comprehensive medical cannabis program. Ballot victories in Missouri and Utah transitioned these states’ low-THC CBD programs to significantly broader access. Voters...
Read moreFrom July 29 through August 2, Americans for Safe Access attended the annual National Conference of State Legislators (NCSL) in Los Angeles, California. We joined over 5,000 conference attendees (about 1,200 of which were state lawmakers or state legislative staff)...
Read moreThis blog post is crossposted from the Releaf App website. Thanks to the results from recently-permitted scientific studies and the untiring work of cannabis activist groups, more and more people are beginning to accept that cannabis is a successful form...
Read moreAlthough there are medical cannabis programs of some kind in 47 states, DC, Guam, and Puerto Rico, medical cannabis still remains a mystery to the vast majority of Americans today. Using medical cannabis is an approach that is supported by...
Read moreThis week medical cannabis patient advocacy groups from Argentina, Mexico, Uruguay, France, Germany, New Zealand, the Netherlands, South Africa, and the United States travelled to Geneva, Switzerland to present to world leaders their recommendations for rescheduling cannabis at the 40th...
Read moreThis week, we submitted comments relating to the efficacy and medical usefulness of cannabis as a medical treatment. In early April, the Food and Drug Administration (FDA) issued a notice in the federal register asking for public comments on cannabis...
Read moreShare this page
ASA serves our mission with the help and support of many organizations and businesses. Click here to learn more about these amazing allies!
